Global warming could spell the end of flu seasons, research released by the National Institution of Health suggests, because the influenza virus better propagates and is more sustainable in colder climates.
Emergent BioSolutions announced that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s pandemic influenza vaccine candidate in the United States.
Drug maker Shire has started a research program focused on rare diseases and their effects on patients and healthcare professionals, the company said Monday.
The Centers for Disease Control and Prevention on Friday reported 12 additional human infections with influenza A (H3N2) variant virus in three states, comprising of one case in Hawaii, 10 cases in Ohio and one case in Indiana.
University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.
Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.
Avian flu researchers have agreed to take a 60-day hiatus on testing an H5N1 influenza strain that recently had gained public attention, according to a letter published Friday in the journal Science.
A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday.
A drug made by Merck for treating HIV infection was effective and tolerated in patients regardless of their gender or race, according to results of a late-stage clinical trial announced Monday.
More than 400 drugs are in late-stage clinical development or awaiting Food and Drug Administration approval as treatments for rare diseases, according to a report by the drug industry lobby.
An investigational drug made by Teva Pharmaceutical Industries for treating allergies is safe and effective, according to results of a late-stage clinical trial announced Wednesday.
Nationwide rates of asthma have been on the rise in recent years, though they’ve risen at a slow pace, according to a new report by the Centers for Disease Control and Prevention.